Business Description
Shine-On BioMedical Co Ltd
ISIN : TW0006926009
Share Class Description:
ROCO:6926: Ordinary SharesDescription
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 320.24 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 84.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.68 | |||||
| 9-Day RSI | 47.85 | |||||
| 14-Day RSI | 49.19 | |||||
| 6-1 Month Momentum % | 2.46 | |||||
| 12-1 Month Momentum % | 4.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 56.04 | |||||
| Quick Ratio | 56.04 | |||||
| Cash Ratio | 55.45 | |||||
| Days Sales Outstanding | 383.24 | |||||
| Days Payable | 365 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | -0.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70 | |||||
| Operating Margin % | -949.01 | |||||
| Net Margin % | -743.71 | |||||
| FCF Margin % | -641.56 | |||||
| ROE % | -6.27 | |||||
| ROA % | -6.18 | |||||
| ROIC % | -1149.13 | |||||
| ROC (Joel Greenblatt) % | -2839.66 | |||||
| ROCE % | -6.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 345.55 | |||||
| PB Ratio | 3.02 | |||||
| Price-to-Tangible-Book | 3.02 | |||||
| EV-to-EBIT | -31.52 | |||||
| EV-to-EBITDA | -32.49 | |||||
| EV-to-Revenue | 230.77 | |||||
| EV-to-FCF | -35.32 | |||||
| Price-to-Net-Current-Asset-Value | 3.04 | |||||
| Price-to-Net-Cash | 3.07 | |||||
| Earnings Yield (Greenblatt) % | -3.16 | |||||
| FCF Yield % | -1.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shine-On BioMedical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 9.524 | ||
| EPS (TTM) (NT$) | -1.42 | ||
| Beta | 0 | ||
| Volatility % | 5.69 | ||
| 14-Day RSI | 49.19 | ||
| 14-Day ATR (NT$) | 1.002276 | ||
| 20-Day SMA (NT$) | 66.18 | ||
| 12-1 Month Momentum % | 4.88 | ||
| 52-Week Range (NT$) | 60.8 - 69.6 | ||
| Shares Outstanding (Mil) | 49.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shine-On BioMedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shine-On BioMedical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shine-On BioMedical Co Ltd Frequently Asked Questions
What is Shine-On BioMedical Co Ltd(ROCO:6926)'s stock price today?
The current price of ROCO:6926 is NT$66.00. The 52 week high of ROCO:6926 is NT$69.60 and 52 week low is NT$60.80.
When is next earnings date of Shine-On BioMedical Co Ltd(ROCO:6926)?
The next earnings date of Shine-On BioMedical Co Ltd(ROCO:6926) is .
Does Shine-On BioMedical Co Ltd(ROCO:6926) pay dividends? If so, how much?
Shine-On BioMedical Co Ltd(ROCO:6926) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers